Accelerate Diagnostics Inc
NASDAQ:AXDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Accelerate Diagnostics Inc
NASDAQ:AXDX
|
US |
|
M
|
MEP Corporation PCL
SET:MEB
|
TH |
|
Protara Therapeutics Inc
NASDAQ:TARA
|
US |
|
K
|
Kikkoman Corp
XMUN:KIK
|
JP |
Wall St Price Targets
AXDX Price Targets Summary
Accelerate Diagnostics Inc
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AXDX's stock price target?
Not Available
AXDX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Accelerate Diagnostics Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 1 year is 7%.